Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man

被引:22
作者
Boeijinga, Peter H.
Soufflet, L.
Santoro, F.
Luthringer, R.
机构
[1] FORENAP, FRP, F-68250 Rouffach, France
[2] FORENAP, FRP, Inst Res Neurosci Neuropharmacol & Psychiat, Rouffach, France
[3] FORENAP Pharma, Rouffach, France
关键词
sensory gating; NMDA receptors; ketamine; human auditory responses; magnetoencephalography; schizophrenia;
D O I
10.1177/0269881107077768
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Disturbances in integrative function have been consistently described in psychotic disorder; for instance, prepulse inhibition of the startle reflex (startle-PPI) which is a marker of sensory gating, is deficient in persons with schizophrenia. The N-methyl-D-aspartate antagonist ketamine produces in control subjects a spectrum of neurobehavioural symptoms like encountered in schizophrenia, and disrupts startLe-PPI in animals. In the present study, we investigated in 12 healthy subjects whether ketamine would reduce sensory-gating in auditory responses at doses which produce psychotic symptoms. in a double-blind, crossover design loading doses of 0.024, 0.081 and 0.27 mg/kg or saline were employed, followed by maintenance infusion for 120 min. A passive paradigm has been developed which consisted in tone bursts, preceded or not by a (near-threshold) click at intervals of 100 ms or 500 ms. Brain electromagnetic activity imaging of the responses to sound stimuli has been carried out by way of a 148-channel magnetoencephatography-system. Actual evoked response amplitudes and underlying equivalent current dipole strengths have been compared to multielectrode evoked potentials from the scalp. A click stimulus is capable to inhibit test responses under placebo at the 100 ms interval. During maintenance infusion of ketamine at steady-state (for >30 min) after 0.27 mg/kg, no such amplitude changes were observed anymore (p < 0.05) and under these circumstances significant increases in Brief Psychiatric Rating scale and Scale for the Assessment of Negative Symptoms scores were evidenced (p < 0.001). Intermediate effects have been observed when the dose was lowered to 0.081 mg/kg. The present results have shown that ketamine may induce a psychotic-like clinical state associated with gating deficits in healthy subjects.
引用
收藏
页码:321 / 337
页数:17
相关论文
共 107 条
  • [1] Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man
    Abduljawad, KAJ
    Langley, RW
    Bradshaw, CM
    Szabadi, E
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1999, 13 (01) : 3 - 9
  • [2] Low dose ketamine increases prepulse inhibition in healthy men
    Abel, KM
    Allin, MPG
    Hemsley, DR
    Geyer, MA
    [J]. NEUROPHARMACOLOGY, 2003, 44 (06) : 729 - 737
  • [3] ADLER LE, 1982, BIOL PSYCHIAT, V17, P639
  • [4] Akbarian S, 1996, J NEUROSCI, V16, P19
  • [5] ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789
  • [6] SYMPTOMS, SIGNS, AND DIAGNOSIS OF SCHIZOPHRENIA
    ANDREASEN, NC
    [J]. LANCET, 1995, 346 (8973) : 477 - 481
  • [7] AMPHETAMINE PSYCHOSIS - BEHAVIORAL AND BIOCHEMICAL ASPECTS
    ANGRIST, B
    SATHANANTHAN, G
    WILK, S
    GERSHON, S
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1974, 11 : 13 - 23
  • [8] THE DISSOCIATIVE ANESTHETICS, KETAMINE AND PHENCYCLIDINE, SELECTIVELY REDUCE EXCITATION OF CENTRAL MAMMALIAN NEURONS BY N-METHYL-ASPARTATE
    ANIS, NA
    BERRY, SC
    BURTON, NR
    LODGE, D
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1983, 79 (02) : 565 - 575
  • [9] A topographic event-related potential follow-up study on 'prepulse inhibition' in first and second episode patients with schizophrenia
    Bender, S
    Schall, U
    Wolstein, J
    Grzella, I
    Zerbin, D
    Oades, RD
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 1999, 90 (01) : 41 - 53
  • [10] Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG
    Blumenfeld, LD
    Clementz, BA
    [J]. CLINICAL NEUROPHYSIOLOGY, 2001, 112 (09) : 1650 - 1659